Status:
WITHDRAWN
PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site
Lead Sponsor:
Rambam Health Care Campus
Conditions:
Treatment of Skin Graft Donor Site
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
PRF Based Dressing Versus AQUACEL® for Local Treatment of Skin Graft Donor Site: A Non-Inferiority Trial
Detailed Description
A prospective single-blind study, where the evaluator is blinded to the treatment. Each patient will be dressed with both Aquacel® and PRF dressing. Half of the donor site area will be dressed with PR...
Eligibility Criteria
Inclusion
- \- Patients with a small burn (2-20% TBSA), who require skin grafting.
Exclusion
- Patients younger than 18 years
- Patients refusing hospitalization
- Patients with heavily infected wounds, which are the probable cause of bacteremia or sepsis.
- Patients with diabetes mellitus or peripheral vascular disease
- Patients under treatment of steroids or other immunosuppressing agents
- Patients with infectious diseases, i.e., HIV, HCV or HBV.
- Patients who are smokers.
- Patients with a known allergy to the dressing.
- Female patients who are pregnant or nursing, psychiatric patients and soldiers.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04749940
Start Date
January 1 2021
End Date
June 1 2021
Last Update
September 24 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam health care campus
Haifa, Israel, 3525408